reduced in concomitant with decreased interstitial cell infiltration. Follow-up of these patients (average 24 Background. With progressive renal disease, structural derangement increasingly encompasses the tubulointer-months) revealed a significant suppression of urinary protein excretion and significant improvement of creatstitial compartment. Tubulointerstitial injury is a critical determinant of renal functional reserve and inine clearance.
phenotype with features of both fibroblasts and smooth neoplasm. The peripheral normal tissues were used for this muscle cells. A pivotal role for myofibroblasts has been study as the controls.
identified in fibrogenesis in non-renal tissues, including skin wound healing, hepatic fibrosis and pulmonary fibrosis [5] . Appearance of myofibroblasts may also Therapy and re-biopsy play a key role in the progression of renal fibrosis in both glomerular and interstitial lesions.
To investigate the effects of glucocorticoid (40 mg/day) and Caldesmon is a major calmodulin-and actin-binding continuous heparin infusion (10 000-25 000 units/day) protein found in smooth muscle and non-muscle cells therapy, re-biopsy was performed after the therapy (4-8 [6 ] . It plays a vital role in the Ca2+-dependent regula-weeks). The target dose of heparin administration was set as tion of smooth muscle and non-muscle contraction [7] . activated partial thromboplastin time (APTT ) prolonged to The two caldesmon isoforms (h-caldesmon and twice those before the therapy. This protocol of the therapy and re-biopsy was evaluated and approved by the committee l-caldesmon) resulting from an alternative splicing have of Department of Internal Medicine and Therapeutics, Osaka been identified. While h-caldesmon is dominantly University School of Medicine. We recommended this protoexpressed in differentiated smooth muscle cells, col to every patient except those who had minor histological l-caldesmon is widely distributed in non-muscle cells.
changes or advanced glomerular changes. Among the 38
In particular, the isoformal interconversion of caldes-cases studied, therapy and re-biopsies were performed in 15 mon is tightly associated with the phenotypic modula-cases who gave consent to this protocol. Written informed tion of smooth muscle cells, in which the caldesmon consents were obtained from all patients who entered this isoform converts from the l-to the h-form during therapy and re-biopsy protocol. Follow-up information differentiation and vice versa [8, 9] . Caldesmon is there-(mean 24 months) was available from 14 patients among fore a favourable molecular marker for studying the these 15 patients. phenotypic modulation of smooth muscle cells. Our recent study in human IgA nephropathy has demonstrated that the glomerular expression of caldesmon is Fixation enhanced in mesangial lesion, and that the quantificaAll tissues except for those of immunoelectron microscopy tion of the caldesmon immunostaining revealed an were fixed in formalin and processed and embedded in association between caldesmon expression and mesangparaffin, utilizing conventional techniques. Tissue blocks ial proliferation in IgA nephropathy [10] . These results were stored at 4°C until use. Four-micrometre-thick serial demonstrate that the enhanced expression of caldes-sections were cut for the immunohistochemical studies as mon is a feature of the phenotypic change in glomerular well as for the conventional periodic acid-Schiff (PAS ) mesangial cells during the progression of proliferative staining and Masson's trichrome staining. glomerulonephritis.
IgA nephropathy, the most common glomerular disease in Japan, occurs in 40-50% of primary glom-Immunohistochemistry erulonephritis, and 40% of IgA nephropathy patients progress to end-stage renal failure. In the present study, Paraffin-embedded sections were deparaffinized with xylene to determine if caldesmon expression is associated with and graded ethanols, then only the sections that would be reacted with anti-caldesmon antibody were heated in an the phenotypic changes of interstitial cells in the pro-800-W microwave oven for 15 min. Next they were exposed gressive renal tubulointerstitial fibrosis, we investigated to 3% hydrogen peroxide in methanol for 5 min to inhibit the interstitial expression of caldesmon in human IgA the endogenous peroxidase activity, and then treated with nephropathy kidneys by immunohistochemical studies, horse serum diluted 1:20 with saline for 20 min to block the using monoclonal antibodies. We found a positive non-specific staining. The sections were then incubated with association between the interstitial expression of caldes-one of the primary mouse monoclonal antibodies for 60 min mon and the pathological changes of the interstitium. at room temperature and subsequently processed using an Furthermore, caldesmon expression was decreased in avidin-biotinylated peroxidase complex method ( Vectastain concomitant with decreased interstitial cell infiltration ABC kit, Vector Laboratories, Inc., Burlingame, CA, USA) after glucocorticoid and heparin therapy. Thus, caldes-with diaminobenzidine as the chromogen. Sections were counterstained with methyl green or haematoxylin.
mon is a reliable marker of the phenotypic changes of interstitial cells in the process of the disease progression of glomerulonephritis. Antibodies
Three mouse monoclonal antibodies were used for immuno-
Subjects and methods
histochemical evaluation. Mouse IgG 1 anti-caldesmon monoclonal antibody, which recognizes both low-and highmolecular-weight isoforms of caldesmon, was obtained from
Patients and tissue samples
YLEM (Roma, Italy) and was used in 1:100 dilution. Mouse IgG 2a
anti-a-SMA monoclonal antibodies were from Tissue samples were obtained by renal biopsy of 38 patients with IgA nephropathy over a 2-year period (April 1995 to Immunotech SA, France. Mouse IgG 1 CD68 monoclonal antibodies which recognized human macrophages were from October 1996 at Osaka University Hospital ). Normal human kidney tissues (n=5) were obtained from kidneys that were Dako (Glostrup, Denmark).
were analysed. Urinary protein excretion and creatinine
Analysis of immunohistochemistry
clearance were also evaluated after 2-year follow-up. Interstitial immunoperoxidase staining for caldesmon and a-SMA in each section was quantified by a computer-aided Statistical analysis manipulator (Quantimet 500 Leica K.K Tokyo Japan). The results were expressed as a fractional volume (Fv) according Values are expressed as the mean±standard deviation. A to the following formula. These analyses were performed by comparison of the caldesmon score between the normal one of the authors, in a blind fashion.
control and IgA nephropathy was performed using the Mann-Whitney U test. A comparison of caldesmon expresFractional volume (Fv %)=(area of positive staining/area sion with histological change (interstitial mononuclear cell of whole field)×100 infiltration and fibrosis) was performed using ANOVA. A Each area was measured quantitatively by a computer-comparison of the Fv of caldesmon between the low-CD68 aided manipulator at a final magnification of ×400. In each group and the intense-CD68 group was performed using the section non-overlapping 10 fields were selected at random Mann-Whitney U test. The correlation of the Fv of caldesand then evaluated. The individual Fv was obtained as the mon and the Fv of a-SMA was performed using Spearman's average Fv of these 10 fields in each section.
rank correlation test. The correlation of the glomerular Glomerular caldesmon expression was also examined, and caldesmon score and the interstitial Fv of caldesmon was the caldesmon score in each glomerulus selected at random performed using Spearman's rank correlation test. The was calculated by the following method.
comparison of the clinical data between the high-intensity and low-intensity groups was performed using the Glomerular caldesmon score (%)=(caldesmon area/whole Mann-Whitney U test. A comparison of each score between glomerular area)×100 before and after glucocorticoid-heparin therapy was perThe whole glomerular area was measured by tracking out formed using the Wilcoxon signed-ranks test. A comparison the glomerular tuft. The caldesmon area which reacted to of the changes in Fv of caldesmon between non-responder anti-caldesmon antibody was measured in the glomerular (patients with unchanged interstitial cell infiltration) and area. In each section, eight glomeruli longer than 160 mm in responder (patients with decreased interstitial cell infiltration) diameter were selected at random and then evaluated. The was performed using the Mann-Whitney U test. individual score was obtained as the average score of these glomeruli in each section.
As to evaluation of CD68 staining, all patients were Results divided into two groups, low CD68 positive cells infiltrated group and intense CD68-infiltrated group. The low CD68 patients for caldesmon immunoreactivity in all cases is given in Figure 1 . In normal controls the interstitial Analysis of histology by light microscopy caldesmon expression was weak. None of the normal kidneys showed prominent interstitial caldesmon Interstitial mononuclear cell infiltration and interstitial expression. On the other hand, the extent of interstitial fibrosis were evaluated semiquantitatively as follows. Interstitial mononuclear cell infiltration was scored as 0-3(0%=0, 0-20%=1, 20-50%=2, >50%=3). Interstitial fibrosis was evaluated by Masson's trichrome-stained sections, and was scored as 0-3(0%=0; 0-20%=1; 20-50%= 2;>50%=3).
Immunoelectron microscopy
Blocks were post-fixed in Zamboni's solution containing 0.05% glutaraldehyde and immersed in a 30% sucrose solution in 0.1 M phosphate buffer (pH 7.40) (PB) overnight until they sank. Then the blocks were frozen in liquid nitrogen for 5-10 s, thawed in PB, and 40-mm thick sections were cut on a vibratone. These sections were processed for immunoelectron microscopy by pre-embedding method described in a previous paper [11] . An avidin-biotinylated peroxidase complex method was used on the labelling technique. (mmHg), serum IgA (mg/dl ), and age at the renal biopsy Enhanced interstitial expression of caldesmon in IgA nephropathy 1411 caldesmon expression in IgA nephropathy kidneys damage is shown. As the severity of the interstitial damage increases, the staining of the caldesmon in the were distributed in a wide range as shown in Figures  1 and 2 . IgA nephropathy patients had significantly interstitium seems to increase accordingly. higher Fv of caldesmon than normal controls. Enhanced interstitial caldesmon expression was virtu-Immunoelectron microscopy ally limited to the area where interstitial pathological
Evaluation of clinical data
The morphology of tissue from IgA nephropathy for changes were observed. In Figure 2 , the representative immunoelectron microscopy with caldesmon was appearance of the interstitial caldesmon expression in adequate to identify individual cells in tubulointerstitial IgA nephropathy with a different degree of interstitial compartment. Interstitial immunolabelling was confined to the cytoplasm of fibroblast-like cells and fibroblast -like processes (Figure 3 ). Glomerular mesangial cells and vascular smooth-muscle cells also demonstrated intracellular cytoplasmic labelling for caldesmon (data not shown). There was no specific immunolabelling in tubular epithelial cells.
A comparison of the leukocyte infiltration and histological changes with the caldesmon expression
We compared the caldesmon expression with the leukocyte infiltration and histological changes using consecutive specimens. Representative illustrations of caldesmon and CD68 immunoreactivity in the interstitium with a prominent mononuclear cell infiltration are shown in Figure 4 . Caldesmon immunoreactivity and Masson's trichrome stain of the consecutive specimen with a moderate interstitial fibrosis are shown in Figure 5 . The caldesmon expression was faint in the interstitium of the caldesmon and a-SMA was detected in the interstitium with prominent mononuclear cell infiltration or with mild to moderate fibrosis. To determine if the caldesmon expression was associ-nuclear cell infiltration score increased ( Figure 6 ). With regard to the fibrotic changes, the Fv of caldesated with the histological changes, we compared the Fv of caldesmon with mononuclear cell infiltration and mon was significantly increased in group 1 compared with group 0. But in case of advanced fibrosis, in fibrosis score. Fv of caldesmon was higher as mono-
between the two groups. As shown in Table 1 , patients in the high urinary protein group had a significantly greater fractional volume of caldesmon and a-SMA than those in the low urinary protein group. With regard to the other clinical parameters, no statistically significant difference were noted between the two groups ( Table 1 ). In addition, interstitial mononuclear cell infiltration and fibrosis score were significantly greater in the high urinary protein group than in the low urinary protein group.
The correlation between a-SMA expression and caldesmon expression of interstitial cells to express a-SMA appears to be an early feature of progressive renal scarring. In this study we have also investigated the interstitial a-SMA expression in the IgA nephropathy kidneys. Using consecutive specimens, co-localization of caldesmon and a-SMA expressions in the interstitium is shown in Figure 9 . The relationship between the Fv of caldesmon and a-SMA is shown (Figure 10 ). There was a statistically significant correlation between caldesmon and a-SMA expression.
The correlation between caldesmon expression in glomeruli and interstitium
Since IgA nephropathy is a primary glomerular disease, changes in the interstitium are considered to be a consequence of glomerular damage. We compared the glomerular and interstitial expressions of caldesmon in individual patients. As shown in Figure 11 , there was a significant correlation between glomerular caldesmon analysis. However, some cases with low glomerular caldesmon scores showed high interstitial Fv of group 2, the caldesmon expression was not increased caldesmon. compared with group 0 (Figure 7) . The Fv of caldesmon and CD68 immunostaining was also compared. The effects of glucocorticoid and heparin therapy Fv of caldesmon was higher in intense-CD68 positive
We investigated the effects of glucocorticoid and concells infiltrated group than in low-CD68 positive cells tinuous heparin infusion therapy on the expression of infiltrated group ( Figure 8 ).
caldesmon and a-SMA, morphological scores and other clinical parameters. Fifteen patients underwent A comparison of the clinical data with the caldesmon re-biopsies after the therapy (4-8 weeks). The immunoexpression staining, morphological scores, and the clinical parameters were compared before and after the therapy. There is clinical evidence that excretion of more than 1 g of protein per day is a bad prognostic feature in Creatinine clearance (Ccr) of those 15 patients before the therapy was 104±38 ml/min. The clinical paraIgA nephropathy. Thus patients were divided into two groups: one that excreted 1 g or more protein per day meters were not changed by the therapy, except that daily urinary protein excretion significantly decreased (high urinary protein group) and one that excreted less than 1 g of protein excreted per day ( low urinary (1.30±1.33 vs 0.435±0.687 g/day). With regard to the morphological score, Fv of caldesmon and a-SMA and protein group). To seek the possible association of the caldesmon expression with the progression of IgA fibrosis score were not significantly decreased after the therapy, but only the mononuclear cell infiltration nephropathy, histological scores (fractional volume of caldesmon and a-SMA, interstitial mononuclear cell score was significantly decreased after the therapy (1.27±0.594 vs 0.867±0.743). So those 15 patients was evaluated. The changes of caldesmon was calcuwere divided into two groups: non-responder (patients lated as follows. with unchanged interstitial cell infiltration) and responder (patients with decreased interstitial cell infil-The changes of caldesmon expression by the therapy =[{Fv of caldesmon(post)−Fv of caldesmon tration). Then between these two groups, the difference in the changes of caldesmon expression by the therapy (pre)}/Fv of caldesmon(pre]×100
The change in Fv of caldesmon was −26.6% in the responder, and was significantly different compared to the non-responder (7.35%) ( Figure 12) , indicating that the Fv of caldesmon decreased in patients with decreased interstitial mononuclear cell infiltration.
In addition we investigated the effects of the therapy after a 2-year follow up. The doses of glucocorticoid tapered off during these 2 years. Fourteen of 15 patients were analysed as to urinary protein excretion (g/day) and creatinine clearance (ml/min) after a 2-year follow up. Creatinine clearance was significantly increased and urinary protein excretion was decreased compared to before the therapy ( Figure 13) .
Discussion
In the present study, we observed that changes in the amount and distribution of caldesmon positive cells within the interstitium of the kidneys from IgA nephropathy patients, and that the quantification of the caldesmon immunostaining revealed an association between caldesmon expression and pathological changes of tubulointerstitial compartment (a-SMA expression, mononuclear cell infiltration, macrophage infiltration and fibrosis) in IgA nephropathy.
Tubulointerstitial injury is an invariant finding in the chronically diseased kidney, irrespective of the type of disease or the compartment in which the disease originates. The decline in renal function has been suggested to correlate better with tubulointerstitial changes than with glomerular damage. The pathways in various compartments of the kidney that culminate in tubulointerstitial injury were: (i) vascular effect; (ii) glomerular injury (proteinuria, haematuria, cytokines, autacoids); (iii) interstitial processes ( lymphocytes, macrophages, fibroblasts, extracellular matrix); (iv) tubular epithelial processes (antigenicity, metabolism, growth factors, cytokines, structural alterations, collagen synthesis); (v) other processes (nephron obstruction, crystalline deposits) [1] . Since IgA nephropathy is a primary glomerular disease, the tubulointerstitial changes in IgA nephropathy patients may first develop from the glomerular injury. We found that in overall patients, glomerular and interstitial caldesmon expressions showed significant correlation. However, we also found that in a few patients the degree of interstitial changes did not correlate with that of glomerular changes. Thus, interstitial processes may partly play Fig. 12 . The difference in the changes of caldesmon expression by roles as an independent factor in the development of the therapy between the following two groups; non-responder tubulointerstitial lesions in IgA nephropathy. In the (patients with unchanged interstitial cell infiltration) and responder present study, our observations were focused on the (patients with decreased interstitial cell infiltration). There is a statistically significant difference between the two groups (P<0.05). interstitial processes, especially on the role of interstitial myofibroblasts. Previous work demonstrated that protein excretion was not increased and renal function was improved and that even short term glucocorticoid interstitial a-SMA expression is enhanced in IgA nephropathy and a-SMA-positive cells are considered therapy could improve clinical states of the disease over 2 years in comparable with the reduction of to be myofibroblasts which are important mediators of tubulointerstitial scarring and have useful prognostic caldesmon expression in tubulointerstitial fibroblasts as well as in glomeruli observed after 4-8 weeks implications [12] . a-SMA is currently considered to be a sensitive marker of the phenotypic change in the duration of the therapy. Although we have not evaluated the histological change after 2-year follow up, we interstitial cells in vivo. Our present study demonstrated an enhanced expression of caldesmon was localized in speculate that the therapy was shown to have a favourable effect on the progression of the disease at least interstitial fibroblast of IgA nephropathy. We have also shown co-localization of caldesmon and a-SMA for 2 years. These results are comparable with the recent report by Kobayashi and colleges [18] . Future expressions in the interstitium to further characterize the phenotype of interstitial myofibroblasts. Thus, cal-long-term follow up is required to evaluate the efficacy of this therapy. How glucocorticoids beneficially infludesmon is a reliable molecular marker of the phenotypic change in the interstitial cells.
ence the interstitial lesions and reverse the phenotype of interstitial cells in IgA nephropathy still remains The concept of the myofibroblast's playing a pivotal role in renal interstitial fibrosis has attracted increasing unclear. Glucocorticoids may have an antiinflammatory effect on the interstitial lesions in IgA attention. The presence of myofibroblasts within the interstitium of patients with IgA nephropathy suggests nephropathy, resulting in decreased interstitial cell infiltration and the reduction of the phenotypic change a role for these cells in the renal scarring. Phenotypic changes of renal interstitial fibroblasts leading to their of interstitial cells. Alternatively, a direct suppression of caldesmon expression by glucocorticoids could be expression of a-SMA and the acquisition of contractile properties would happen during the progression of the mechanism; however, so far, there has been no report on the direct action of glucocorticoids on caldesIgA nephropathy. However, we cannot exclude that myofibroblasts appeared to be derived from the cortical mon in smooth-muscle cells or interstitial cells in culture. arterial and arteriolar walls and diffuse into the interstitium and accumulate in the periglomerular and peritub-
In the present study, we used heparin in addition to glucocorticoids. Heparin was demonstrated to suppress ular space. Immunoelectron microscopy revealed that activated mesangial cells as well as interstitial mesangial cell proliferation and matrix expansion in anti-Thy 1.1 glomerulonephritis [19] . Thus, heparin fibroblasts expressed caldesmon but tubular cells did not, suggesting that the epithelial-mesenchymal trans-may also have beneficial effects in vivo in IgA nephropathy patients. However, there was a report that formation may not occur in IgA nephropathy. Moreover, the prominent periglomerular and peritubu-heparin induced a-SMA expression in cultured fibroblasts [20] . Thus it is unlikely that heparin directly lar distribution of a-SMA is consistent with the pattern of collagen mRNA expressing cells seen in experi-suppressed the interstitial a-SMA expression in IgA nephropathy patients. mental interstitial fibrosis [13] . In in vitro cell culture study, renal fibroblasts have been shown to produce
Of note is the fact that the distribution pattern of caldesmon in the interstitium was enhanced particucollagen in response to a variety of stimuli, including cytokines and growth factors [14, 15] . Fibroblasts larly in the perivascular, periglomerular and peritubular lesion and was similar to that of a-SMA in IgA cultured from diseased kidneys exhibit significant abnormal hyperproliferative growth and collagen bio-nephropathy. The degree of response to the therapy was also similar between caldesmon and a-SMA. Our synthesis when compared to their normal counterparts.
Our present study demonstrates that the presence of previous study demonstrated that the similar up-regulation of caldesmon and a-SMA were observed myofibroblasts in the renal interstitium correlates well with interstitial leukocyte infiltrates, including macro-in the mesangial lesion in IgA nephropathy. Taken together, we speculate that to a large extent, the gene phages. Leukocytes have a role in activation and recruitment of fibroblast-like cells. Interestingly, results regulation of caldesmon and a-SMA is mediated by the same molecular mechanism in the phenotypic of a cell culture study suggest that leukocyte-derived transforming growth factor b may act as a stimulus change of interstitial and mesangial cells in the process of glomerulonephritis. for acquisition of myofibroblast features [16 ] . Investigators using several model systems have also
In fact, there are several common sequence elements within the promoter of caldesmon and a-SMA. For shown that macrophage-derived TGF-b1 may be pivotal in the process of myofibroblast modulation [17] . example, CArG elements exist in the 5∞ regulatory regions of both genes and they appear to be the targets Another major finding in this study is that glucocorticoid-heparin therapy (4-8 weeks) seemed to suppress of growth-factor-induced signals that produce a rapid transcriptional activation of the caldesmon and a-SMA the interstitial expression of caldesmon and a-SMA in the patients with decreased interstitial cell infiltration. gene [21, 22] . However, the involvement of CArG element in the transcriptional regulation of a-SMA It supports the idea that leukocyte-derived growth factors and/or cytokines may act as a stimulus for and caldesmon in the process of myofibroblast formation has not been elucidated. We are investigating the acquisition of myofibroblast features. In the present study, we also found that after 2-year follow up urinary molecular mechanism of myofibroblast formation
